Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Support letter for inclusion of Daclatasvir on 4th March, 2015.
Strategies to Secure Access to Generic HCV Medicines
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Simplified HCV Treatment* for Treatment-Naive Patients Without Cirrhosis
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Flawed patents on hepatitis C drugs latest to be challenged in global push for access